title: Sizing Up Pfizer After Drug Pricing Deal Finalized With Trump Administration
source: Yahoo
date: 2025-10-08
url: https://finnhub.io/api/news?id=58299def87d3814309221352b74d1a34f933eb35a7baea55ba8f1482fd08ffa4
If you are watching Pfizer right now and feeling uncertain about whether to stay, buy, or even take profits, you are definitely not alone. Over the last month, Pfizerâ€™s stock has climbed 5.6%, including a recent 3.1% push in just a week. But this rebound is set against a much tougher long-term backdrop, with shares still down 1.3% year-to-date and off 3.7% over the past year. The bigger picture shows a longer slide of 26.1% in three years and nearly 5% in five years. Clearly, investors have...
